HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,019.00
-39.00 (-3.69%)
At close: Nov 13, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 46.39 billion as of November 13, 2026. It is the 32,337th most valuable company in the world and the 1,808th biggest in South Korea. Its market cap has decreased by 40.19% in one year.
Market Cap
46.39B
Enterprise Value
28.10B
Revenue
14.71B
Global Rank
Country Rank
#1,808 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 46.39B, an increase of 168.32%. That is a compound annual growth rate of 3.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 46.39B | -41.23% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 211.30B |
| Dx & Vx | 204.24B |
| GC Medical Science | 69.37B |
| Inventera | 60.57B |
| Cytogen | 53.65B |
| GENINUS | 53.53B |
| Protia | 53.23B |
| Seoulin Bioscience | 29.06B |